PHARMADIRECT A/S: Financial statements 2012
CVR: 34221138
Source: annual report 2012, Danish Business Authority
25/01/2012 – 31/12/2012
PHARMADIRECT A/S (CVR 34221138) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -18,170 and a net result of DKK -18,170. Equity in the 2012 report amounted to DKK 481,830. The solvency ratio was 99%.
- Gross Profit
- DKK -18,170
- Profit/Loss
- DKK -18,170
- Equity
- DKK 481,830
- Total Assets
- DKK 486,830
Official annual report
Keep an eye on PHARMADIRECT A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 25, 2012, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMADIRECT A/S.
As of January 25, 2012, Ejvind Sandal has joined the board of directors of PHARMADIRECT A/S.
As of January 25, 2012, Aksel Emanuel Bjørke has joined the board of directors of PHARMADIRECT A/S.
As of January 25, 2012, Peter Johnsen is registered as adm. dir. of PHARMADIRECT A/S.
PHARMADIRECT A/S was founded on January 25, 2012.
About PHARMADIRECT A/S
PHARMADIRECT A/S was a Danish company of the type Aktieselskab based in Køge, founded in 2012. The company has been dissolved on 6 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2016). In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -29,034 compared with DKK -27,431 the year before. Equity in the 2022 report amounted to DKK 2,410,080.